Sectors & IndustriesHealthcareBiotechnology
Best Biotech Stocks to Buy Now (2025)
Top biotech stocks in 2025 ranked by overall Zen Rating. "A" Rated stocks have returned an average of +32.52% per year, and are the best biotech stocks to buy now. Learn More.

Industry: Biotechnology
F
Biotech is Zen Rated F and is the 140th ranked industry out of 145 stock market industries
Learn how the Zen Ratings work
Ticker
Company
Price
1d %
1w %
1m %
3m %
6m %
1y %
3y %
5y %
10y %
52-week High
52-week Low
% off 52-week High
% off 52-week Low
Beta
Volume
Vol 1d %
AUPH
AURINIA PHARMACEUTICALS INC
$8.18-0.61%-0.12%4.60%0.86%-12.70%52.90%-19.33%-49.82%139.88%$10.67$5.2023.34%57.46%1.07942,00010.05%
EXEL
EXELIXIS INC
$41.59-0.45%-3.35%12.56%13.02%18.73%89.39%135.90%82.41%1,105.51%$48.85$21.3614.86%94.71%0.632,132,000-2.78%
CPRX
CATALYST PHARMACEUTICALS INC
$23.53-3.13%-9.05%-0.51%12.75%10.06%53.49%277.69%435.99%489.72%$26.58$14.7511.47%59.53%1.061,113,000-44.57%
RIGL
RIGEL PHARMACEUTICALS INC
$20.52-3.66%-4.51%12.19%3.06%8.51%110.70%195.98%10.32%-42.03%$29.82$7.4831.19%174.18%1.35145,00030.63%
HALO
HALOZYME THERAPEUTICS INC
$53.98-1.03%-0.50%7.47%-11.60%12.46%8.79%25.24%133.17%164.22%$70.51$42.0123.44%28.49%0.871,219,0007.69%
PBYI
PUMA BIOTECHNOLOGY INC
$3.35-5.90%-9.95%11.30%0.30%16.32%0.90%27.38%-64.92%-97.42%$4.13$2.2318.89%50.56%0.97319,00093.33%
BCRX
BIOCRYST PHARMACEUTICALS INC
$10.37-0.29%-6.07%3.08%37.53%37.72%66.45%10.91%130.96%-16.17%$11.31$5.928.31%75.17%1.172,661,000-30.23%
PTCT
PTC THERAPEUTICS INC
$51.260.55%-1.67%10.50%-2.84%10.55%38.92%100.23%4.12%2.01%$58.38$28.7212.20%78.48%0.99751,00025.59%
CRMD
CORMEDIX INC
$14.56-2.02%4.15%25.19%40.27%73.75%198.36%403.81%145.12%-41.99%$15.38$3.615.33%303.32%1.001,184,000-6.62%
BMRN
BIOMARIN PHARMACEUTICAL INC
$56.22-1.85%-0.76%-5.96%-20.37%-14.83%-33.26%-21.82%-46.84%-53.89%$94.85$52.9340.73%6.22%0.751,623,00013.66%
INCY
INCYTE CORP
$67.75-2.12%-1.48%11.41%0.06%-1.17%8.07%0.00%-27.55%-34.65%$83.95$53.5619.30%26.49%0.601,835,00050.66%
NAGE
NIAGEN BIOSCIENCE INC
$13.63-3.61%5.25%40.08%76.55%122.71%325.94%670.06%224.52%275.48%$14.49$2.315.94%491.32%1.25880,000-2.87%
HRMY
HARMONY BIOSCIENCES HOLDINGS INC
$32.97-1.08%-7.39%-4.07%0.76%1.79%10.79%-25.96%N/AN/A$41.61$26.4720.76%24.56%0.85787,000-28.19%
ZVRA
ZEVRA THERAPEUTICS INC
$9.13-2.56%-1.40%16.01%14.99%7.67%85.95%111.34%186.75%-96.59%$9.76$4.206.45%117.38%0.79534,00011.25%
CSBR
CHAMPIONS ONCOLOGY INC
$7.663.58%11.18%22.66%-13.84%21.01%48.74%0.13%-16.10%30.27%$11.99$3.6036.11%112.78%0.4999,000-61.48%
ONC
BEONE MEDICINES LTD
$269.63-2.50%5.38%19.98%5.92%50.34%62.06%106.93%57.23%N/A$287.88$141.316.34%90.81%0.95392,000-45.86%
AKBA
AKEBIA THERAPEUTICS INC
$3.56-2.47%-10.33%43.55%110.65%92.43%217.86%870.03%-70.65%-55.94%$4.08$0.8012.66%345.00%1.676,476,00057.41%
THTX
THERATECHNOLOGIES INC
$2.48-1.98%-3.88%-5.34%63.16%63.16%96.83%-73.16%-67.37%-40.95%$3.13$1.1220.77%121.43%0.71201,000200.00%
ARWR
ARROWHEAD PHARMACEUTICALS INC
$15.74-2.96%-6.37%3.01%4.45%-27.96%-40.60%-44.34%-52.62%133.53%$30.41$9.5748.24%64.47%1.581,219,000-16.91%
PLX
PROTALIX BIOTHERAPEUTICS INC
$1.49-3.25%-5.70%-10.24%-31.34%-17.22%28.45%36.70%-60.37%-92.47%$3.10$0.8251.94%81.49%0.61500,0009.89%
VCYT
VERACYTE INC
$26.44-0.94%-3.71%-9.79%-13.11%-38.82%21.34%65.66%6.27%135.23%$47.32$19.7344.12%34.01%1.95954,00023.26%
XOMA
XOMA ROYALTY CORP
$23.85-3.05%-5.54%-13.24%17.66%-12.15%-10.67%23.83%11.40%-67.60%$35.00$18.3531.86%29.96%0.8436,000164.71%
MDXG
MIMEDX GROUP INC
$6.04-1.31%-6.93%-15.76%-23.45%-34.06%-12.59%90.54%N/A-40.20%$10.14$5.4740.43%10.42%1.22940,00086.51%
INVA
INNOVIVA INC
$21.691.36%0.51%18.78%24.73%16.74%35.65%50.42%65.45%15.62%$21.98$15.701.30%38.15%0.491,422,000-1.46%
MNKD
MANNKIND CORP
$3.71-3.13%-15.30%-21.40%-27.96%-43.27%-26.39%-3.64%123.49%-87.84%$7.63$3.7051.38%0.27%1.111,781,000-4.40%
HRTX
HERON THERAPEUTICS INC
$1.93-3.98%-8.10%4.89%-16.81%20.63%-46.91%-16.09%-89.93%-93.94%$3.73$1.0448.26%85.58%1.46748,0006.40%
XLO
XILIO THERAPEUTICS INC
$0.66-3.22%-5.43%-42.43%-17.15%-31.68%-36.95%-73.52%N/AN/A$1.70$0.6261.06%6.77%0.92374,000-15.58%
ZLAB
ZAI LAB LTD
$41.00-4.72%7.58%43.26%13.45%55.72%108.23%62.83%-44.12%N/A$44.34$16.017.53%156.09%1.251,019,000-42.36%
NVO
NOVO NORDISK A S
$79.83-1.51%6.97%22.06%5.19%-25.36%-43.98%48.41%144.20%183.94%$148.15$57.0046.12%40.05%0.607,467,000-29.20%
BDTX
BLACK DIAMOND THERAPEUTICS INC
$2.31-4.94%-10.47%19.69%40.00%-9.77%-62.56%8.45%-93.92%N/A$6.75$1.2065.78%93.31%1.48568,000-47.65%
KNSA
KINIKSA PHARMACEUTICALS INTERNATIONAL PLC
$28.302.06%-6.38%10.55%27.71%40.10%50.85%248.09%20.63%N/A$30.69$17.387.79%62.83%0.87907,000-32.11%
IMCR
IMMUNOCORE HOLDINGS PLC
$34.68-2.67%-6.90%21.47%22.67%19.96%-12.62%22.20%N/AN/A$41.54$23.1516.51%49.81%0.75435,000-59.19%
GMAB
GENMAB A
$22.82-1.17%2.79%18.18%14.33%13.14%-13.59%-18.00%-26.65%157.47%$28.56$17.2420.10%32.40%0.741,113,0008.48%
VIVS
VIVOSIM LABS INC
$1.61-6.94%-12.50%-14.36%-66.64%-66.84%-85.88%-93.22%-98.80%-99.88%$21.96$1.5692.67%3.21%0.8445,600-25.73%
MIRM
MIRUM PHARMACEUTICALS INC
$49.631.24%7.01%9.63%11.38%16.94%86.02%145.45%181.83%N/A$54.23$27.108.49%83.14%0.76442,00016.62%
STOK
STOKE THERAPEUTICS INC
$11.53-2.45%3.50%29.12%42.17%-4.39%-34.19%10.44%-50.66%N/A$16.62$5.3530.63%115.51%1.38478,000-4.40%
FENC
FENNEC PHARMACEUTICALS INC
$7.93-4.69%-5.93%22.38%29.36%31.07%15.26%44.05%-10.14%250.88%$8.72$3.969.06%100.25%0.6765,000-22.62%
RPRX
ROYALTY PHARMA PLC
$34.84-1.22%3.14%6.15%6.61%40.26%28.09%-9.41%-21.71%N/A$35.38$24.051.53%44.86%0.533,525,000-60.61%
VRNA
VERONA PHARMA PLC
$92.20-0.32%9.32%36.45%41.06%122.60%492.54%1,908.71%1,673.08%N/A$93.74$14.141.64%552.05%0.78754,000-45.24%
VXRT
VAXART INC
$0.7030.73%73.33%69.16%35.78%18.58%-6.40%-75.19%-71.46%-96.89%$1.07$0.2934.39%146.32%1.5929,050,000195.64%
TECH
BIO-TECHNE CORP
$50.52-1.96%3.76%-2.11%-15.63%-33.25%-34.29%-37.82%-20.55%106.01%$83.62$46.0139.58%9.80%1.161,874,0004.63%
VRTX
VERTEX PHARMACEUTICALS INC
$455.45-1.00%1.10%5.43%-9.44%-1.79%-4.92%85.60%70.09%268.80%$519.88$377.8512.39%20.54%0.601,022,000-4.84%
ALNY
ALNYLAM PHARMACEUTICALS INC
$307.991.09%2.38%15.41%27.40%25.48%92.43%141.18%139.90%137.37%$310.22$152.300.72%102.23%0.92572,000-34.55%
IMAB
I-MAB
$2.49-3.49%1.63%170.65%196.43%149.00%33.87%-72.02%-91.31%N/A$3.08$0.6019.02%318.49%1.17391,000-23.48%
UTHR
UNITED THERAPEUTICS CORP
$283.35-0.98%-13.03%-8.02%-7.22%-21.69%-1.47%30.90%149.14%52.46%$417.82$266.9832.18%6.13%0.48564,000-46.79%
ARGX
ARGENX SE
$577.89-1.51%-1.37%6.53%-0.57%-4.83%48.81%75.36%162.65%N/A$678.21$377.4714.79%53.10%0.67297,0003.85%
TGTX
TG THERAPEUTICS INC
$36.01-3.64%-10.11%7.91%-2.83%12.46%114.86%771.91%97.97%141.84%$46.48$16.2122.53%122.15%1.911,671,000-40.11%
ATRA
ATARA BIOTHERAPEUTICS INC
$8.821.26%-4.44%32.04%28.57%-14.62%-33.12%-93.04%-96.62%-99.37%$18.71$5.0152.85%76.22%1.8434,000-20.93%
ARQT
ARCUTIS BIOTHERAPEUTICS INC
$13.43-0.52%-6.54%-2.82%-9.32%5.83%43.79%-32.88%-54.41%N/A$17.75$7.6424.34%75.90%1.172,230,00062.77%
XERS
XERIS BIOPHARMA HOLDINGS INC
$4.35-1.58%-5.02%-11.22%-4.61%32.62%95.95%170.19%-3.55%N/A$6.07$2.0328.34%114.29%1.181,777,00063.78%
NVAX
NOVAVAX INC
$6.94-2.94%-6.85%12.12%-15.06%-23.82%-53.89%-80.87%-86.41%-96.09%$17.81$5.0161.03%38.52%1.635,180,00029.47%
TLX
TELIX PHARMACEUTICALS LTD
$16.09-7.85%-4.05%-3.71%-5.30%2.09%N/AN/AN/AN/A$30.36$13.6147.00%18.22%0.8733,200-32.79%
TBPH
THERAVANCE BIOPHARMA INC
$10.690.75%-4.98%19.98%15.19%8.20%24.59%23.44%-54.66%-25.09%$11.82$7.449.56%43.68%0.62190,000-38.71%
TARS
TARSUS PHARMACEUTICALS INC
$40.89-0.15%-6.90%-1.37%-12.01%-22.11%23.39%225.56%N/AN/A$57.28$20.0828.61%103.62%0.90716,0003.77%
ACAD
ACADIA PHARMACEUTICALS INC
$21.71-0.14%-1.23%26.22%29.38%25.78%43.87%29.46%-53.30%-44.42%$25.23$13.4013.95%62.01%0.891,154,000-25.79%
WHWK
WHITEHAWK THERAPEUTICS INC
$1.96-3.92%4.81%18.79%1.55%-18.67%16.67%-84.69%-90.03%N/A$3.81$1.2148.58%61.98%0.8281,000-8.99%
GLUE
MONTE ROSA THERAPEUTICS INC
$4.91-0.20%-2.00%21.53%-20.93%-35.05%22.44%-28.74%N/AN/A$12.40$3.2160.40%52.96%1.69381,000-7.75%
ZYME
ZYMEWORKS INC
$12.67-3.28%0.56%9.13%0.96%0.72%39.08%132.05%-64.43%N/A$17.70$8.2128.42%54.32%0.94613,00086.89%
KROS
KEROS THERAPEUTICS INC
$13.56-0.59%-9.84%0.67%18.22%-27.99%-72.61%-50.82%-61.87%N/A$72.37$9.1281.26%48.68%1.13378,000-22.70%
CTMX
CYTOMX THERAPEUTICS INC
$2.75-8.03%4.17%10.00%365.31%147.75%88.36%57.14%-65.80%N/A$3.10$0.4011.15%587.50%1.321,975,0009.97%
AGEN
AGENUS INC
$4.70-2.49%-21.01%39.05%180.60%54.10%-70.63%-82.33%-93.49%-97.57%$18.74$1.3874.92%240.58%1.61402,000-41.65%
LGND
LIGAND PHARMACEUTICALS INC
$112.50-1.70%6.14%6.50%6.51%-3.77%38.31%50.97%0.91%24.61%$129.90$77.5313.39%45.11%1.0983,000-31.97%
FTRE
FORTREA HOLDINGS INC
$5.91-5.74%11.93%18.20%-38.31%-70.45%-76.07%N/AN/AN/A$28.41$3.9779.20%48.87%1.482,989,000-30.54%
CORT
CORCEPT THERAPEUTICS INC
$70.06-1.57%0.66%-0.75%27.73%26.46%122.34%240.59%360.01%986.20%$117.33$28.0440.29%149.86%0.941,009,000-35.07%
SEER
SEER INC
$2.07-2.82%-9.21%7.81%5.08%-16.19%14.36%-69.20%N/AN/A$2.63$1.5621.14%32.69%1.81184,00023.49%
KRYS
KRYSTAL BIOTECH INC
$137.07-2.32%0.09%1.89%-22.72%-16.24%-24.98%168.66%201.45%N/A$219.34$122.8037.51%11.62%1.37295,000-31.24%
RGNX
REGENXBIO INC
$9.27-9.12%-3.54%13.33%41.53%11.96%-29.13%-52.87%-74.82%N/A$15.36$5.0439.65%84.11%1.37798,00046.96%
TVRD
TVARDI THERAPEUTICS INC
$24.62-5.71%-13.61%-7.23%62.19%161.03%54.16%-91.15%-95.59%-93.68%$34.31$8.1328.24%203.02%0.9852,0002.97%
PVLA
PALVELLA THERAPEUTICS INC
$25.05-5.19%-1.38%8.35%-7.84%84.19%150.50%-81.02%-89.83%-90.15%$29.27$6.2014.42%304.03%0.77224,000239.39%
IPSC
CENTURY THERAPEUTICS INC
$0.58-4.17%-6.66%9.32%3.05%-52.87%-82.36%-92.78%N/AN/A$3.30$0.3482.58%68.13%1.25758,00088.56%
TVTX
TRAVERE THERAPEUTICS INC
$14.50-2.95%-5.35%-30.75%-24.20%-16.28%100.28%-38.03%-7.94%-53.07%$25.29$6.8042.67%113.24%1.051,583,000-55.87%
SEPN
SEPTERNA INC
$10.17-2.31%-0.39%51.11%59.15%-54.58%N/AN/AN/AN/A$28.99$4.1764.92%143.88%1.38299,000-29.65%
GYRE
GYRE THERAPEUTICS INC
$7.99-0.99%-4.99%-30.52%-33.19%-17.12%-27.63%-59.95%-92.96%-99.82%$19.00$6.1157.95%30.77%1.22144,000-21.74%
MESO
MESOBLAST LTD
$11.78-3.13%-0.08%-1.09%-11.30%0.17%61.59%123.95%-53.14%N/A$22.00$5.7846.45%103.81%1.30124,000-42.33%
FHTX
FOGHORN THERAPEUTICS INC
$4.32-4.85%-3.14%-0.23%-3.57%-18.49%-22.99%-64.88%N/AN/A$10.25$2.9557.85%46.69%1.4867,500-15.63%
TSHA
TAYSHA GENE THERAPIES INC
$2.54-4.15%-10.56%8.55%47.67%22.71%-39.09%-7.30%N/AN/A$4.07$1.0537.59%141.90%1.822,461,000-41.56%
ACIU
AC IMMUNE SA
$1.95-5.80%-4.41%24.20%-15.22%-33.90%-58.77%-38.29%-71.49%N/A$4.41$1.4355.78%36.36%1.09134,00098.52%
NTRB
NUTRIBAND INC
$7.15-5.92%-7.14%24.78%16.83%72.71%19.17%122.46%-20.93%N/A$11.78$3.7239.30%92.10%0.5432,00052.38%
ACOG
ALPHA COGNITION INC
$9.35-2.65%-0.27%35.31%66.07%72.51%N/AN/AN/AN/A$11.40$3.7517.98%149.33%0.9080,00019.40%
MCRB
SERES THERAPEUTICS INC
$7.50-6.13%-8.87%1.76%-41.26%-57.32%-47.21%-86.46%-91.79%N/A$30.60$6.5375.49%14.85%1.3437,800-37.00%
MDGL
MADRIGAL PHARMACEUTICALS INC
$295.57-0.55%6.23%0.07%-8.50%-2.93%6.70%329.36%173.55%257.83%$377.46$200.6321.70%47.32%0.79271,000-28.50%
ADMA
ADMA BIOLOGICS INC
$20.81-3.66%0.97%4.68%16.19%11.94%93.04%995.26%573.46%144.54%$25.67$10.2118.93%103.82%1.102,766,000-23.76%
AEON
AEON BIOPHARMA INC
$0.912.13%11.10%81.47%51.58%-98.12%-99.07%-99.87%N/AN/A$269.28$0.3899.66%142.93%0.17393,000-17.95%
KYMR
KYMERA THERAPEUTICS INC
$46.96-0.70%-1.39%50.80%40.39%11.46%34.67%231.40%N/AN/A$53.27$19.4511.85%141.50%1.63470,000-9.62%
ABVC
ABVC BIOPHARMA INC
$1.77-4.32%14.94%5.36%157.27%250.50%113.25%-83.46%N/AN/A$1.85$0.404.32%342.50%0.57285,000-21.49%
GERN
GERON CORP
$1.51-3.21%-5.63%25.83%-9.58%-60.88%-69.06%17.97%-10.12%-61.38%$5.06$1.1770.16%29.06%1.127,485,00010.79%
FOLD
AMICUS THERAPEUTICS INC
$6.03-2.27%-2.11%0.17%-31.56%-35.58%-43.35%-23.48%-45.87%-56.93%$12.65$5.8152.33%3.79%1.034,225,0009.54%
FULC
FULCRUM THERAPEUTICS INC
$6.851.03%-5.52%18.31%136.21%72.98%-12.18%63.10%-59.82%N/A$10.13$2.3232.38%195.90%1.25247,000-18.21%
ADPT
ADAPTIVE BIOTECHNOLOGIES CORP
$10.32-0.86%2.28%11.09%43.93%63.81%212.73%61.25%-76.80%N/A$10.87$2.995.06%245.15%1.96979,0000.41%
REGN
REGENERON PHARMACEUTICALS INC
$529.241.42%7.30%-7.82%-22.24%-27.63%-48.44%-3.65%-10.38%6.05%$1.21k$476.4956.30%11.07%0.64952,0009.05%
ARVN
ARVINAS INC
$7.39-2.38%-1.86%17.49%-13.57%-62.10%-72.06%-80.01%-76.08%N/A$34.11$5.9078.33%25.25%1.351,131,000-1.31%
CADL
CANDEL THERAPEUTICS INC
$5.13-4.29%-15.07%-4.91%-35.39%-24.00%-31.96%54.52%N/AN/A$14.60$3.7964.86%35.54%1.06727,0006.13%
IMNM
IMMUNOME INC
$9.20-6.03%0.77%16.31%3.02%-26.87%-42.64%198.70%N/AN/A$16.81$5.1545.27%78.64%1.421,258,00054.36%
SLS
SELLAS LIFE SCIENCES GROUP INC
$1.660.61%3.11%17.73%43.10%90.37%14.48%-27.19%-45.75%-100.00%$2.12$0.7721.70%115.03%1.002,639,000-2.94%
AAPG
ASCENTAGE PHARMA GROUP INTERNATIONAL
$31.51-1.59%11.03%31.07%69.14%N/AN/AN/AN/AN/A$32.15$17.001.99%85.35%0.532,800-86.27%
LEGN
LEGEND BIOTECH CORP
$36.83-2.85%5.23%18.50%-3.21%4.87%-15.66%-14.37%-4.21%N/A$60.87$27.3439.49%34.71%0.771,555,000-59.40%
CNTA
CENTESSA PHARMACEUTICALS PLC
$12.382.82%3.86%-0.64%-26.62%-25.29%24.67%224.93%N/AN/A$19.09$8.4635.15%46.34%1.001,039,000100.58%
GOSS
GOSSAMER BIO INC
$1.24-2.36%-6.77%13.76%-4.62%33.33%139.85%-79.77%-90.07%N/A$1.55$0.5220.00%138.46%1.331,127,0008.57%
ASND
ASCENDIS PHARMA A
$170.80-0.07%-1.31%5.75%12.14%31.52%33.60%113.61%20.38%874.89%$183.00$111.096.67%53.75%0.71370,00048.00%
RARE
ULTRAGENYX PHARMACEUTICAL INC
$37.49-4.58%0.87%5.90%-4.48%-18.11%-13.06%-21.37%-45.83%-57.71%$60.37$29.5937.90%26.70%1.121,094,000-43.02%

Biotech Stocks FAQ

What are the best biotech stocks to buy right now in Jun 2025?

According to Zen Ratings, our proprietary rating system that evaluates 115 factors proven to drive growth in stocks and assigns each stock in our system an overall letter grade as well as 7 individual Component Grades for Value, Growth, Momentum, Sentiment, Safety, Financials, and proprietary AI algorithms, the 3 best biotechnology stocks to buy right now are:

1. Aurinia Pharmaceuticals (NASDAQ:AUPH)


Aurinia Pharmaceuticals (NASDAQ:AUPH) is the #1 top biotech stock out of 653 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Aurinia Pharmaceuticals (NASDAQ:AUPH) is: Value: B, Growth: B, Momentum: C, Sentiment: A, Safety: C, Financials: A, and AI: C.

Aurinia Pharmaceuticals (NASDAQ:AUPH) has a Due Diligence Score of 62, which is 38 points higher than the biotech industry average of 24.

AUPH passed 20 out of 33 due diligence checks and has strong fundamentals. Aurinia Pharmaceuticals has seen its stock return 52.9% over the past year, overperforming other biotech stocks by 129 percentage points.

2. Exelixis (NASDAQ:EXEL)


Exelixis (NASDAQ:EXEL) is the #2 top biotech stock out of 653 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Exelixis (NASDAQ:EXEL) is: Value: A, Growth: C, Momentum: C, Sentiment: A, Safety: C, Financials: A, and AI: C.

Exelixis (NASDAQ:EXEL) has a Due Diligence Score of 67, which is 43 points higher than the biotech industry average of 24.

EXEL passed 22 out of 33 due diligence checks and has strong fundamentals. Exelixis has seen its stock return 89.39% over the past year, overperforming other biotech stocks by 166 percentage points.

Exelixis has an average 1 year price target of $39.94, a downside of -3.97% from Exelixis's current stock price of $41.59.

Exelixis stock has a consensus Buy recommendation according to Wall Street analysts. Of the 16 analysts covering Exelixis, 31.25% have issued a Strong Buy rating, 18.75% have issued a Buy, 50% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

3. Catalyst Pharmaceuticals (NASDAQ:CPRX)


Catalyst Pharmaceuticals (NASDAQ:CPRX) is the #3 top biotech stock out of 653 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Catalyst Pharmaceuticals (NASDAQ:CPRX) is: Value: A, Growth: C, Momentum: C, Sentiment: A, Safety: D, Financials: A, and AI: C.

Catalyst Pharmaceuticals (NASDAQ:CPRX) has a Due Diligence Score of 73, which is 49 points higher than the biotech industry average of 24.

CPRX passed 24 out of 33 due diligence checks and has strong fundamentals. Catalyst Pharmaceuticals has seen its stock return 53.49% over the past year, overperforming other biotech stocks by 130 percentage points.

Catalyst Pharmaceuticals has an average 1 year price target of $32.50, an upside of 38.12% from Catalyst Pharmaceuticals's current stock price of $23.53.

Catalyst Pharmaceuticals stock has a consensus Strong Buy recommendation according to Wall Street analysts. Of the 4 analysts covering Catalyst Pharmaceuticals, 50% have issued a Strong Buy rating, 50% have issued a Buy, 0% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

What are the biotech stocks with highest dividends?

Out of 5 biotech stocks that have issued dividends in the past year, the 3 biotech stocks with the highest dividend yields are:

1. Dominari Holdings (NASDAQ:DOMH)


Dominari Holdings (NASDAQ:DOMH) has an annual dividend yield of 6.58%, which is 5 percentage points higher than the biotech industry average of 1.63%.

Dominari Holdings's dividend payout ratio of -7.1% indicates that its high dividend yield might not be sustainable for the long-term.

2. Novo Nordisk (Ozempic) (NYSE:NVO)


Novo Nordisk (Ozempic) (NYSE:NVO) has an annual dividend yield of 2.02%, which is the same as the biotech industry average of 1.63%. Novo Nordisk (Ozempic)'s dividend payout is not stable, having dropped more than 10% ten times in the last 10 years. Novo Nordisk (Ozempic)'s dividend has shown consistent growth over the last 10 years.

Novo Nordisk (Ozempic)'s dividend payout ratio of 45.2% indicates that its dividend yield is sustainable for the long-term.

3. Royalty Pharma (NASDAQ:RPRX)


Royalty Pharma (NASDAQ:RPRX) has an annual dividend yield of 1.87%, which is the same as the biotech industry average of 1.63%. Royalty Pharma's dividend payout is stable, having never dropped by more than 10% in the last 10 years. Royalty Pharma's dividend has shown consistent growth over the last 10 years.

Royalty Pharma's dividend payout ratio of 34.4% indicates that its dividend yield is sustainable for the long-term.

Why are biotech stocks down?

Biotech stocks were down -1.4% in the last day, and down -1.07% over the last week. Biorestorative Therapies was the among the top losers in the biotechnology industry, dropping -16% yesterday.

BioRestorative Therapies shares are trading lower. The company announced the presentation of promising preliminary blinded data from the first 36 subjects in its ongoing Phase 2 clinical trial of BRTX-100.

What are the most undervalued biotech stocks?

Based on the Valuation rating, one of the 7 components of a stocks overall Zen Ratings grade, which evaluates factors including estimated earnings yield, earnings before interest and taxes/enterprise value, cash flow yield, free cash flow to price, and price-to-earnings growth (PEG ratio), the 3 most undervalued biotech stocks right now are:

1. Puma Biotechnology (NASDAQ:PBYI)


Puma Biotechnology (NASDAQ:PBYI) is the most undervalued biotech stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Puma Biotechnology has a valuation score of 43, which is 28 points higher than the biotech industry average of 15. It passed 3 out of 7 valuation due diligence checks.

Puma Biotechnology's stock has gained 0.9% in the past year. It has overperformed other stocks in the biotech industry by 77 percentage points.

2. Harmony Biosciences Holdings (NASDAQ:HRMY)


Harmony Biosciences Holdings (NASDAQ:HRMY) is the second most undervalued biotech stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Harmony Biosciences Holdings has a valuation score of 71, which is 56 points higher than the biotech industry average of 15. It passed 5 out of 7 valuation due diligence checks.

Harmony Biosciences Holdings's stock has gained 10.79% in the past year. It has overperformed other stocks in the biotech industry by 87 percentage points.

3. United Therapeutics (NASDAQ:UTHR)


United Therapeutics (NASDAQ:UTHR) is the third most undervalued biotech stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

United Therapeutics has a valuation score of 71, which is 56 points higher than the biotech industry average of 15. It passed 5 out of 7 valuation due diligence checks.

United Therapeutics's stock has dropped -1.47% in the past year. It has overperformed other stocks in the biotech industry by 75 percentage points.

Are biotech stocks a good buy now?

53.31% of biotech stocks rated by analysts are a strong buy right now. On average, analysts expect biotech stocks to rise by 99.94% over the next year.

2.39% of biotech stocks have a Zen Rating of A (Strong Buy), 4.56% of biotech stocks are rated B (Buy), 35.57% are rated C (Hold), 36.66% are rated D (Sell), and 20.82% are rated F (Strong Sell).

What is the average p/e ratio of the biotechnology industry?

The average P/E ratio of the biotechnology industry is -108.97x.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.